Jo Vandervoort

5.1k total citations
67 papers, 3.0k citations indexed

About

Jo Vandervoort is a scholar working on Surgery, Pharmaceutical Science and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jo Vandervoort has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 21 papers in Pharmaceutical Science and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jo Vandervoort's work include Advanced Drug Delivery Systems (18 papers), Gallbladder and Bile Duct Disorders (16 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). Jo Vandervoort is often cited by papers focused on Advanced Drug Delivery Systems (18 papers), Gallbladder and Bile Duct Disorders (16 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). Jo Vandervoort collaborates with scholars based in Belgium, United States and Denmark. Jo Vandervoort's co-authors include A. Ludwig, Andreas Ludwig, Kathleen Dillen, David R. Lichtenstein, Henry Montes, Roy Soetikno, Tony Tham, Jacques Van Dam, David L. Carr‐Locke and Guy Van den Mooter and has published in prestigious journals such as Gut, Journal of Controlled Release and The American Journal of Gastroenterology.

In The Last Decade

Jo Vandervoort

66 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Vandervoort Belgium 28 1.5k 1.2k 1.0k 867 486 67 3.0k
Vandana Soni India 30 1.2k 0.8× 552 0.5× 261 0.3× 486 0.6× 600 1.2× 143 2.9k
R. S. R. Murthy India 39 301 0.2× 255 0.2× 378 0.4× 1.7k 1.9× 1.5k 3.1× 103 4.4k
Jan Fallingborg Denmark 21 712 0.5× 218 0.2× 220 0.2× 282 0.3× 80 0.2× 58 2.8k
Rahul Kumar Verma India 26 150 0.1× 726 0.6× 134 0.1× 627 0.7× 361 0.7× 92 2.3k
Li Yang China 30 267 0.2× 224 0.2× 314 0.3× 170 0.2× 553 1.1× 164 2.9k
Don Haeng Lee South Korea 29 1.6k 1.1× 1.4k 1.2× 739 0.7× 86 0.1× 523 1.1× 180 2.9k
Francisca Araújo Portugal 31 325 0.2× 139 0.1× 236 0.2× 1.2k 1.4× 752 1.5× 53 3.0k
P Speiser Switzerland 33 231 0.2× 274 0.2× 345 0.3× 1.2k 1.4× 1.4k 2.8× 129 3.7k
Dae Hwan Kang South Korea 36 1.9k 1.3× 2.1k 1.8× 1.0k 1.0× 104 0.1× 572 1.2× 247 4.5k
Markus Vogt Switzerland 27 781 0.5× 196 0.2× 259 0.2× 339 0.4× 48 0.1× 60 2.8k

Countries citing papers authored by Jo Vandervoort

Since Specialization
Citations

This map shows the geographic impact of Jo Vandervoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Vandervoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Vandervoort more than expected).

Fields of papers citing papers by Jo Vandervoort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Vandervoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Vandervoort. The network helps show where Jo Vandervoort may publish in the future.

Co-authorship network of co-authors of Jo Vandervoort

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Vandervoort. A scholar is included among the top collaborators of Jo Vandervoort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Vandervoort. Jo Vandervoort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wauters, Lucas, et al.. (2021). Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience. Acta Gastro Enterologica Belgica. 84(1). 19–24. 1 indexed citations
2.
3.
Jiménez-Pérez, Javier, Juan Antonio Casellas, Jesús García-Cano, et al.. (2011). Colonic Stenting as a Bridge to Surgery in Malignant Large-Bowel Obstruction: A Report from Two Large Multinational Registries. The American Journal of Gastroenterology. 106(12). 2174–2180. 79 indexed citations
4.
Vermeersch, M, An Matheeussen, Jo Vandervoort, et al.. (2011). PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: Factor influence study and in vitro efficacy evaluation. International Journal of Pharmaceutics. 420(1). 122–132. 48 indexed citations
5.
Yoncheva, Krassimira, Jo Vandervoort, & Andreas Ludwig. (2009). Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application. Pharmaceutical Development and Technology. 16(1). 29–35. 41 indexed citations
6.
Bebrevska, Lidiya, et al.. (2007). Development and Validation of an HPLC Method for Quality Control of Pueraria lobata Flower. Planta Medica. 73(15). 1606–1613. 12 indexed citations
7.
Weyenberg, Wim, et al.. (2007). Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. International Journal of Pharmaceutics. 337(1-2). 291–298. 82 indexed citations
8.
Dillen, Kathleen, Chris H. Bridts, Pieter Van der Veken, et al.. (2007). Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomonas. International Journal of Pharmaceutics. 349(1-2). 234–240. 52 indexed citations
9.
Vandervoort, Jo. (2007). Microneedles for transdermal drug delivery: a minireview. Frontiers in bioscience. 13(13). 1711–1711. 48 indexed citations
10.
Dillen, Kathleen, Jo Vandervoort, Guy Van den Mooter, Loes Verheyden, & Andreas Ludwig. (2004). Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. International Journal of Pharmaceutics. 275(1-2). 171–187. 143 indexed citations
11.
Dillen, Kathleen, Wim Weyenberg, Jo Vandervoort, & Andreas Ludwig. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 58(3). 539–549. 35 indexed citations
12.
Tham, Tony, Jo Vandervoort, Richard C.K. Wong, et al.. (2003). Safety of ERCP during pregnancy. The American Journal of Gastroenterology. 98(2). 308–311. 78 indexed citations
13.
Vandervoort, Jo & A. Ludwig. (2003). Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. European Journal of Pharmaceutics and Biopharmaceutics. 57(2). 251–261. 184 indexed citations
14.
Vandervoort, Jo, Roy Soetikno, Tony Tham, et al.. (2002). Risk factors for complications after performance of ERCP. Gastrointestinal Endoscopy. 56(5). 652–656. 118 indexed citations
15.
Vandervoort, Jo, et al.. (2000). Endoscopic Treatment of a Perforated Duodenal Diverticulum. Endoscopy. 32(12). 991–993. 18 indexed citations
16.
Vandervoort, Jo, Roy Soetikno, Henry Montes, et al.. (1999). Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointestinal Endoscopy. 49(3). 322–327. 114 indexed citations
17.
Tham, Tony, David L. Carr‐Locke, Jo Vandervoort, et al.. (1998). Management of occluded biliary Wallstents. Gut. 42(5). 703–707. 69 indexed citations
18.
Soetikno, Roy, David R. Lichtenstein, Jo Vandervoort, et al.. (1998). Palliation of malignant gastric outlet obstruction using an endoscopically placed Wallstent. Gastrointestinal Endoscopy. 47(3). 267–270. 84 indexed citations
19.
Tham, Tony, et al.. (1997). Therapeutic ERCP in outpatients. Gastrointestinal Endoscopy. 45(3). 225–230. 27 indexed citations
20.
Vandervoort, Jo, et al.. (1996). Self-expanding metal stent for obstructing adenocarcinoma of the sigmoid. Gastrointestinal Endoscopy. 44(6). 739–741. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vandana Soni Breakdown of academic impact, for papers by R. S. R. Murthy Breakdown of academic impact, for papers by Jan Fallingborg Breakdown of academic impact, for papers by Rahul Kumar Verma Breakdown of academic impact, for papers by Li Yang Breakdown of academic impact, for papers by Don Haeng Lee Breakdown of academic impact, for papers by Francisca Araújo Breakdown of academic impact, for papers by P Speiser Breakdown of academic impact, for papers by Dae Hwan Kang Breakdown of academic impact, for papers by Markus Vogt
Rankless by CCL
2026